India orders top drugmaker to halt eye medicine production at plant over quality lapses
India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses Reuters Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops: Management BusinessLine India orders Sun Pharma to halt eye-care drug production at plant...
Key Takeaways
- India orders top drugmaker to halt eye medicine production at plant over quality lapses
- India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses Reuters Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops: Management BusinessLine India orders Sun Pharma to halt eye-care drug production at plant after quality lapses TradingView India halts Sun Pharma eye drug production over quality issues UA.NEWS
- Click full coverage link below for the complete official dispatch.
India orders top drugmaker to halt eye medicine production at plant over quality lapses CNA EXCLUSIVE: India orders Sun Pharma to halt eye-care drug production at plant after quality lapses Reuters Sun Pharma taking remedial action, following voluntary withdrawal of 11 eye drops: Management BusinessLine India orders Sun Pharma to halt eye-care drug production at plant after quality lapses TradingView India halts Sun Pharma eye drug production over quality issues UA.NEWS
Original Publisher Attribution
This summary was curated from CNA.